Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined SubgroupsKevin Y. Urayama, Eva Ardanáz, Nikolaus Becker et al.|JNCI Journal of the National Cancer Institute|2012Cited by 171
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E.D. Chamuleau, Marie José Kersten, Coreline N. Burggraaff et al.|Haematologica|2019Cited by 53
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphomaPier Luigi Zinzani, F. Morschhauser, Lionel Karlin et al.|Haematologica|2016Cited by 48
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimensLiesbeth E.M. Oosten, Hendrik Veelken, Martine E.D. Chamuleau et al.|Annals of Hematology|2017Cited by 44